Glucose-Lowering Medications, Glycemia, and Cognitive OutcomesJosé A. Luchsinger, Erica Gonzalez, Samuel P. Rosin et al.|JAMA Internal Medicine|2025Cited by 10
Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)Kristina M. Utzschneider, E. Gonzalez Hattery, Mark Tripputi et al.|Diabetes Care|2025Cited by 2
Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) CohortRodica Pop‐Busui, J. Jimenez, Silvio E. Inzucchi et al.|Diabetes Care|2025Cited by 1